Daiichi Sankyo
Karen Scheetz is a seasoned professional with extensive experience in site contracts, budget management, and procurement within the pharmaceutical industry. Currently serving as Associate Director of Site Contracts & Budget Management at Daiichi Sankyo, Inc. since July 2021, Karen previously held managerial roles at The Janssen Pharmaceutical Companies of Johnson & Johnson from July 2015 to July 2021, focusing on fair market value pricing for clinical trial agreements. Karen's earlier tenure at Merck from July 2000 to March 2015 included positions such as Senior Specialist in Business Planning & Supplier Management and Clinical Trial Registration and Results Posting Operations Lead, where regulatory compliance and financial support for clinical trials were key responsibilities. A graduate of Rutgers University with a Bachelor's degree, Karen has consistently demonstrated a strong ability to facilitate communication, provide training, and manage financial operations throughout diverse roles in the industry.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.